(Q46655061)

24 December 2017

title

Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockers (English)

1 reference

24 December 2017

1 reference

4

1 reference

24 December 2017

Oliver Zolk

9

1 reference

24 December 2017

author name string

Dierk Werner

1

1 reference

24 December 2017

Ulrike Werner

2

1 reference

24 December 2017

Annett Meybaum

3

1 reference

24 December 2017

Sumaira Umbreen

5

1 reference

24 December 2017

Anton Grosch

6

1 reference

24 December 2017

Heiko G Lestin

7

1 reference

24 December 2017

Bernhard Graf

8

1 reference

24 December 2017

Martin F Fromm

10

1 reference

24 December 2017

publication date

1 January 2008

1 reference

24 December 2017

Clinical Pharmacokinetics

published in

1 reference

24 December 2017

volume

47

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

323-332

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.2165/00003088-200847050-00003

exact match

0 references

cites work

In vitro inhibition screening of human hepatic P450 enzymes by five angiotensin-II receptor antagonists

1 reference

12 December 2020

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

1 reference

12 December 2020

Pharmacogenomics of human OATP transporters

1 reference

12 December 2020

Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators

1 reference

12 December 2020

Anti-aldosteronergic effect of torasemide

1 reference

12 December 2020

Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans

1 reference

12 December 2020

1 reference

12 December 2020

Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites

1 reference

12 December 2020

Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry

1 reference

12 December 2020

Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers

1 reference

12 December 2020

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

1 reference

12 December 2020

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

1 reference

12 December 2020

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

12 December 2020

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

1 reference

12 December 2020

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

1 reference

12 December 2020

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

1 reference

12 December 2020

Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism

1 reference

12 December 2020

Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters

1 reference

12 December 2020

Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes

1 reference

12 December 2020

EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.

1 reference

12 December 2020

A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane

1 reference

12 December 2020

The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Role of CYP2C9 polymorphism in losartan oxidation

1 reference

12 December 2020

Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels

1 reference

12 December 2020

Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study

1 reference

12 December 2020

Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry

1 reference

12 December 2020

Effects of gender on the pharmacokinetics of drugs secreted by the renal organic anions transport systems in the rat.

1 reference

12 December 2020

CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide

1 reference

12 December 2020

Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of torasemide

1 reference

12 December 2020

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

1 reference

12 December 2020

Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide

1 reference

12 December 2020

Torasemide transport by organic anion transporters contributes to hyperuricemia

1 reference

12 December 2020

The influence of sex on pharmacokinetics

1 reference

12 December 2020

Genetic variation at the CYP2C locus and its association with torsemide biotransformation

1 reference

12 December 2020

The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerations

1 reference

12 December 2020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

12 December 2020

10.2165/00003088-200847050-00003

Identifiers

DOI

1 reference

24 December 2017

Dimensions Publication ID

0 references

1 reference

24 December 2017